Sort comments by
Newest
Upvotes

Never Miss a Live Debate. Become a Member.

Join the newsletter and get all of our updates easily in one place.

Never Miss a Live Debate. Become a Member.

Join the newsletter and get all of our updates easily in one place.

Never Miss a Live Debate. Become a Member.

Join the newsletter and get all of our updates easily in one place.

April 9, 2021

Agree to Disagree COVID Series: Vaccine Patents

India and South Africa have petitioned the World Trade Organization to suspend intellectual property protections for Covid-19 vaccines. These nations – along with a coalition of scholars, activists, and nonprofit organizations – argue that developing nations are at risk of waiting years to get full access to the vaccines unless these protections are lifted. But their opponents say suspending patent protections will do little to speed up the manufacturing process. Instead, undermining these protections will ensure that the next time the world needs an emergency vaccine, governments and pharmaceuticals will be unable to act as swiftly. It’s a debate emblematic of the uneven vaccine rollout, and strikes at the core of society’s ability to act quickly.

ABOUT THE DEBATERS
Thomas Cueni
Thomas Cueni - Director General, International Federation of Pharmaceutical Manufacturers & Associations
Thomas Cueni is Director General of IFPMA, the global association of pharmaceutical research compani... Read bio
Brook Baker
Brook Baker - Professor, Northeastern University
Professor Baker teaches disability discrimination law, negotiations and a new course on human rights... Read bio